Literature DB >> 18987306

Serum phosphorus levels associate with coronary atherosclerosis in young adults.

Robert N Foley1, Allan J Collins, Charles A Herzog, Areef Ishani, Philip A Kalra.   

Abstract

Phosphorus levels correlate with atherosclerosis in both animal models and humans with advanced chronic kidney disease, but whether this relationship exists among individuals with normal kidney function is unknown. This study aimed to determine whether an association exists between phosphorus levels and coronary artery calcium levels in a community-based cohort of 3015 healthy young adults in the prospective Coronary Artery Risk Development in Young Adults (CARDIA) study. Phosphorus levels were measured at baseline, and presence of coronary artery calcium was assessed by computed tomography 15 yr later. Mean age at study inception was 25.2 yr, and the mean levels of phosphorus and calcium were 3.6 and 9.5 mg/dl, respectively. Only 0.2% of participants had estimated GFR <60 ml/min per 1.73 m(2). Phosphorus levels were associated with coronary artery calcium in unadjusted models. In multivariate models, however, phosphorus levels were significantly associated with the category of coronary artery calcium level. In conclusion, higher serum phosphorus levels, even within the normal range, may be a risk factor for coronary artery atherosclerosis in healthy young adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987306      PMCID: PMC2637043          DOI: 10.1681/ASN.2008020141

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  40 in total

Review 1.  Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology.

Authors:  Matthew J Budoff; Stephan Achenbach; Roger S Blumenthal; J Jeffrey Carr; Jonathan G Goldin; Philip Greenland; Alan D Guerci; Joao A C Lima; Daniel J Rader; Geoffrey D Rubin; Leslee J Shaw; Susan E Wiegers
Journal:  Circulation       Date:  2006-10-02       Impact factor: 29.690

2.  Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.

Authors:  Yelena Slinin; Robert N Foley; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2005-04-06       Impact factor: 10.121

Review 3.  Reducing the burden of cardiovascular calcification in patients with chronic kidney disease.

Authors:  Wajeh Y Qunibi
Journal:  J Am Soc Nephrol       Date:  2005-11       Impact factor: 10.121

4.  Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.

Authors:  Marcello Tonelli; Frank Sacks; Marc Pfeffer; Zhiwei Gao; Gary Curhan
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

5.  Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events.

Authors:  N D Wong; J C Hsu; R C Detrano; G Diamond; H Eisenberg; J M Gardin
Journal:  Am J Cardiol       Date:  2000-09-01       Impact factor: 2.778

6.  Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease: comparison with cardiac risk factors and radionuclide perfusion imaging.

Authors:  A Schmermund; A E Denktas; J A Rumberger; T F Christian; P F Sheedy; K R Bailey; R S Schwartz
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

7.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

Authors:  Despina Sitara; Mohammed S Razzaque; Martina Hesse; Subbiah Yoganathan; Takashi Taguchi; Reinhold G Erben; Harald Jüppner; Beate Lanske
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

8.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

9.  Estrogen therapy and coronary-artery calcification.

Authors:  Joann E Manson; Matthew A Allison; Jacques E Rossouw; J Jeffrey Carr; Robert D Langer; Judith Hsia; Lewis H Kuller; Barbara B Cochrane; Julie R Hunt; Shari E Ludlam; Mary B Pettinger; Margery Gass; Karen L Margolis; Lauren Nathan; Judith K Ockene; Ross L Prentice; John Robbins; Marcia L Stefanick
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

10.  Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.

Authors:  Ravi Dhingra; Lisa M Sullivan; Caroline S Fox; Thomas J Wang; Ralph B D'Agostino; J Michael Gaziano; Ramachandran S Vasan
Journal:  Arch Intern Med       Date:  2007-05-14
View more
  139 in total

1.  Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.

Authors:  Orlando M Gutiérrez; Tamara Isakova; Gwen Enfield; Myles Wolf
Journal:  J Ren Nutr       Date:  2010-05-26       Impact factor: 3.655

2.  Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.

Authors:  Orlando M Gutiérrez; Tamara Isakova; Kelsey Smith; Michael Epstein; Neha Patel; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2010-06-07       Impact factor: 5.992

3.  Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men study.

Authors:  Jerry Meng; Claes Ohlsson; Gail A Laughlin; Michel Chonchol; Christina L Wassel; Osten Ljunggren; Magnus K Karlsson; Dan Mellstrom; Eric S Orwoll; Elizabeth Barrett-Connor; Joachim H Ix
Journal:  Kidney Int       Date:  2010-06-09       Impact factor: 10.612

4.  A murine model of phosphate nephropathy.

Authors:  Philipp Eller; Kathrin Eller; Alexander H Kirsch; Josef J Patsch; Anna M Wolf; Andrea Tagwerker; Ursula Stanzl; Reinhard Kaindl; Volker Kahlenberg; Gert Mayer; Josef R Patsch; Alexander R Rosenkranz
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

5.  Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons.

Authors:  Andy I Choi; Eric Vittinghoff; Steven G Deeks; Cristin C Weekley; Yongmei Li; Michael G Shlipak
Journal:  AIDS       Date:  2011-06-19       Impact factor: 4.177

6.  Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.

Authors:  Jessica Houston; Kelsey Smith; Tamara Isakova; Nicole Sowden; Myles Wolf; Orlando M Gutiérrez
Journal:  J Ren Nutr       Date:  2012-03-09       Impact factor: 3.655

Review 7.  The role of phosphorus in the development and progression of vascular calcification.

Authors:  Jessica Kendrick; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2011-09-28       Impact factor: 8.860

Review 8.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

9.  Interaction of Serum Phosphate with Age as Predictors of Cardiovascular Risk Scores in Stable Renal Transplant Recipients.

Authors:  Jillian Kerry; Holly Mansell; Hamdi Elmoselhi; Mike Moser; Ahmed Shoker
Journal:  Int J Angiol       Date:  2016-12-12

Review 10.  Phosphate imbalance in patients with heart failure.

Authors:  E C Christopoulou; T D Filippatos; E Megapanou; M S Elisaf; G Liamis
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.